GraniteShares Advisors’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-6,878
Closed -$954K 95
2024
Q1
$954K Buy
6,878
+462
+7% +$58.1K 0.5% 66
2023
Q4
$796K Sell
6,416
-1,550
-19% -$158K 0.72% 67
2023
Q3
$743K Buy
+7,966
New +$898K 0.69% 66
2022
Q2
Sell
-1,796
Closed -$229K 152
2022
Q1
$229K Sell
1,796
-52
-3% -$5.69K 0.12% 150
2021
Q4
$248K Buy
+1,848
New +$266K 0.11% 161

Other funds holding DXCM

GraniteShares Advisors's DXCM Position: Q2 2024 in Review

GraniteShares Advisors sold out of DexCom (DXCM) in Q2 2024, closing a stake of 6,878 shares — an estimated $954K sold.

GraniteShares Advisors first reported a position in DXCM in Q4 2021 and held it in 5 quarters. The position peaked at $954K in Q1 2024. 999 funds tracked by Wall St. Rank hold DXCM as of Q2 2024.

  • GraniteShares Advisors reported no remaining DexCom position as of Q2 2024 after selling out during the quarter.
  • GraniteShares Advisors sold 6,878 DexCom shares in Q2 2024, an estimated $954K.
  • GraniteShares Advisors first reported a position in DexCom in Q4 2021 and held it in 5 quarters.
  • GraniteShares Advisors's DexCom position peaked at $954K in Q1 2024.
  • 999 funds tracked by Wall St. Rank held DexCom as of Q2 2024.

Based on GraniteShares Advisors's 13F filing for Q2 2024, filed 1 Aug 2024.